Fisher & Paykel Healthcare Corporation Limited Stock
Equities
FPH
NZFAPE0001S2
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30 NZD | -1.64% | +1.69% | +27.12% |
Sales 2025 * | 1.96B 1.19B | Sales 2026 * | 2.18B 1.33B | Capitalization | 17.52B 10.7B |
---|---|---|---|---|---|
Net income 2025 * | 340M 208M | Net income 2026 * | 410M 250M | EV / Sales 2025 * | 8.95 x |
Net cash position 2025 * | 9.71M 5.93M | Net cash position 2026 * | 16.62M 10.15M | EV / Sales 2026 * | 8.03 x |
P/E ratio 2025 * |
51.4
x | P/E ratio 2026 * |
42.8
x | Employees | 7,005 |
Yield 2025 * |
1.46% | Yield 2026 * |
1.64% | Free-Float | 90.59% |
Latest transcript on Fisher & Paykel Healthcare Corporation Limited
1 day | -1.64% | ||
1 week | +1.69% | ||
Current month | +1.69% | ||
1 month | +4.53% | ||
3 months | +20.58% | ||
6 months | +25.00% | ||
Current year | +27.12% |
Managers | Title | Age | Since |
---|---|---|---|
Lewis Gradon
CEO | Chief Executive Officer | 63 | 84-12-31 |
Lyndal York
DFI | Director of Finance/CFO | - | 19-02-28 |
Dexter Cheung
CTO | Chief Tech/Sci/R&D Officer | - | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Daniell
BRD | Director/Board Member | 66 | 90-04-30 |
Scott St. John
CHM | Chairman | - | 15-09-30 |
Lewis Gradon
CEO | Chief Executive Officer | 63 | 84-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.15% | 15 M€ | -4.01% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 30 | -1.64% | 496,521 |
24-06-06 | 30.5 | -2.40% | 672,300 |
24-06-05 | 31.25 | +3.82% | 496,713 |
24-06-04 | 30.1 | +2.03% | 487,524 |
End-of-day quote New Zealand S.E., June 06, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.12% | 10.7B | |
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
-6.87% | 23.32B | |
-10.63% | 22.92B |
- Stock Market
- Equities
- FPH Stock